Form 8-K

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

Current Report Pursuant

to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) June 3, 2003

 

 

Natus Medical Incorporated

(Exact name of registrant as specified in its charter)

 

Delaware

  

000-33001

  

77-0154833

(State or other

jurisdiction of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

1501 Industrial Road,

San Carlos, California

  

94070

(Address of principal executive offices)

  

(Zip Code)

 

Registrant’s telephone number, including area code: (650) 802-0400

 

Not applicable

(Former name or former address, if changed since last report)

 

 

ITEM 5. OTHER EVENTS AND REQUIRED REGULATION FD DISCLOSURE.

 

On June 3, 2003, Natus Medical Incorporated (the “Company”) issued a press release regarding the appointment of Steven J. Murphy as vice president, finance and the resignation of Glenn A. Bauer, its chief financial officer. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

 

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

 

(c) Exhibits.

 

Exhibit No.

   

Description

99.1

   

Press release dated June 3, 2003.

 

-2-

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

NATUS MEDICAL INCORPORATED

Dated: June 9, 2003

      

By:

  

/s/    Tim C. Johnson        

           

Tim C. Johnson

President, Chief Executive Officer and Chief

Operating Officer

 

 

-3-

 

Index to Exhibits

 

Exhibit No.

   

Description

99.1

   

Press release dated June 3, 2003.

 

-4-